• 検索結果がありません。

Twinkleトップページ - 東京女子医科大学学術リポジトリ

N/A
N/A
Protected

Academic year: 2021

シェア "Twinkleトップページ - 東京女子医科大学学術リポジトリ"

Copied!
8
0
0

読み込み中.... (全文を見る)

全文

(1)

Review lJTok 川 omMe 吋dU 凶 8 6 (artxE 1り)E2~E9(ρ2016)

N

e

u

r

o

p

s

y

c

h

i

a

t

r

i

c

Syndromes

due

S

o

t

m

i

c

s

t

e

y

Lupus

Erythematosus

or

I

n

d

u

c

d

e

by C

:

s

d

i

o

r

e

t

s

o

c

i

t

r

o

A P

c

i

r

t

a

i

h

c

y

s

e

v

i

t

c

e

p

s

e

r

P

Katsuji NISHIMURA and Jun ISHIGOOKA D e p a r t m e n t Pfoyrtaihcys lo, ohcS Mfoenicide , Tkyoo Women's lacideM ytisrevinU ( A c c e p t e d rebotcO 31)5,102 S y s t e m i c supul sustoemahtyre )ELS( sidetaicossa ithw a hhgi ecnedicni pfocirtaihcys .snoitatsefinam How 同 e v e

r t, isi unknown whether sihtnoitaicossa si a dtceri ecnueqnseoc afoevitc SLE , iantceridn epiphenomenon -sa

s o c i a t e d hitw eht esaesid irost ypareht , aro en 旺tce deatlernu Sot E.L pnIralucitra gnihsiug, nitsid -dioretsocitroc i n d u c e d cirtaihcysp redrosid )PDIC( omrf cirtaihcysporuen snoitatsefinam SLE fo (NPSLE) si dtolsuciffi taht-inilc c i a n s era netfo tughca ni a tcituepareh gnikam-noisiced .amemild The srohtua summarize tnecer erutaretil -er g a r d i n

g ehtlacinilc stcepsa pfocirtaihcys syndromes NPSLE fo nitsartnoc hitw s.DPIC Based londetimi seiduts , d e l i r i u

m s, isochysp , and reeves-o-tetaredom evitingoc noitcnufsyd may more eb eivtseggus NPSLEfo yllai, cepse

i n sesac denimpaocca by rksi srotcaf NPSLE fo .g.e( , deasercni lareneg esaesid ytivitca , suoiverp stneve , rehto c o n c u r r e n t NPSLE snoitatsefinam , proyltnetsisre evitisop dipilohpsohpitna .)seidobitna lyseernvoC , mood -rosid d e r

s hitw manic/mixed serutaef may more eb evtiseggus CIPDfo yllaic, epse retfa etuca es, od-hgih dioretsocitroc

t h e r a p y

. However , NPSLE and CIPD nca hotb tneserp ssorca a sumpectr pfocirtaihcys .semordnys ughAltho -er

c e n

t seiduts eavh detsgegus some lufesu noitamrofni taht anc make rof retteb management tfoeseh detacilpomc c o n d i t i o n s lu, ferac citsongaid snoitagitsevni gnidulcni acinilc ,lyrotarobal , and niarb ginmagi sgnidnif dlouhs be c o n d u c t e d on a cesac-yb-esa .sisab Key W o:sdrdecudni-dioretsocitroc cirtaihcysp sredrosid cirtaihcy, sporuen supul , cmietsys supul ussotaemyther I n t r o d u c t i o n A vtyeria fo ciogolruen and citraihcysp -nsy dromes lyntueeqfr occur nitsneitap with imcsyste l u p u s erythematosus E)SL( , a ccniorh and -gnispaler r e m i t t i n g autoimmune myotarmalfni esaseid ト)4 N ecitraihycpsour sniottaesfniam fo SLE (NPSLE) a r e deaticsosa with a neivatge impact on pisosognr , q u a l i t y foefil , llarevo damage fo het easesid , and working tilibasid y.)5 At the same time -ret, socitroc o i d s , het nestoernroc treatment fo rof SLE , era -erf q u e n t l y deaticsosa with resveda cirtiahcysp stceffe , i n c l u d i n g evitceffa sredrsoid , ciotchsyp serdorsid , and umiireld 6 )-8). I n ecitacrp , ti si netfo tluciffid ot hsiugnitsid c o r t i c o s t e r o i d -i n d u c e d cirtaihcyps rdersoid (CIPD) from NPSLE 0191 ) . When SLE stenitap on c-retsocitro o i d

s sentpre new cirtiahcysp symptoms , an emerg-i

n

g lacinilc dilemma usrcco over whether eth -sod age fosdioretsocitroc dlhuos be ddesaerce ro -ni c r e a s e d . tIn sih review , we pvidero an overview fo c l i n i c a l sctpesa pfociratihcys syndromes NPSLE fo i n

ctsraton with CIPDs make ot rof retetb manage-ment fo ehest deicatmlopc .snoitidnoc Data -er t r i e v e d rof eth noitcrutsnoc tfo he review were -bo t a i n e

d from two main :sceruos aggregated -refer e

n c e

s taken from entrec eswrive and a PubMed s e a r c h ingcover eht tasp twenty .sraey 図 :ijustaK NISHIMURA tnemtrapeD foyrtaihcysP , loohcS foenicideM , okyoT ns'oemW lacideM ytisrevinU , 8-1 K a w a d a -c h o uk-uku, jnihS , oykoT 666, 8-261 J anpa E -m a i l : [email protected]

(2)

Primary and secondary NPSLE D e s p i t e a high encdeicin pfocirtiahcys -tasfeniam t i o n

s edtiaocsas with SLE , tisi tno known whether t

h i

s noitaicossa si a dtceri consequence sfo ystemic autoimmunity and noiatmmalfni .g.e( , entry ifo m

-mune sllec and uelscelom otni eht larntec nervous system ])SCN[ “(primary NPSLE") , an itceridn e妊cte a s csontiicalpmo tfo he eseasid .g.e( , uremia hor y -p e r t e n s i o n ) irost therapy .g.e( )sdioretsoc, itroc “(-ces ondary NPSLE") , an e旺ero tc detalernu SLE ot .g.e( , i n f e c t i o n s , colitabem seitialrmonba , ro adverse m e d i c a t i o n e妊e')Stc ! )-14).1 In 9199 , eth American -loC l e g e Rheumatology fo (ACR) hcsearer ommitteeωc p u b l i s h e d ecas snoitinifed rof NPSLE 91 syndromes i n c l u d i n g C21 ldeater-SN syndromes and 7 p-hipre e r a

l nervous detaler-metsys syndromes. However ,

t h

enoitacifissalc was tno ylirassecen cificeps rof irp 圃

mary SLE because no dcitsnogai ldgo standard fo primary SLE .detsixe a mIn sisylnaa-ate fo s17 -dut i e s gnitgaistevni NPSLE ngplyiap het 9199 ACR c a s e snoitinifed , Unterman te 1a4 ) edestimat a-revp l e n c e s tfo eh gnwiollof cirtaichysp syndromes: mood d i s o r d e r (20.7%) , eviitngoc noictunfsyd 1(9.7%) , a n x i e t y rdeorisd 6,()%4. sioshcysp )%6.4( , and uteac c o n f u s i o n a l etats 3(%).4 bleaT( .)1 A legra tyjorima o f eth mood rsdeorsdi fo NPSLE ear nsioresdep w h i l e mania siylrear etnserp , ginccurro ni -xioprpa mately lyon 3 % o pfstnieta 2 ) . A i n i a l a te la)l conducted a canoitces-ssor ,l-ulppo a t i o n -b a s e d study aot ssses eth ytidilav tfo he ACR nomenclature rof NPSLE. Forty-two 19( %) fo 46 p-a t

i e n t

s and 25 (56%) fo 46 cslrotno matched by age ,

sex , onatiduce , and ceapl fo cendesire dellifluf ta l

e a s

t one tfo eh ACR NPSLE .airetirc etvinigoC -sdy f u n c t i o

n was het most common syndrome cteddete i n 7 p3 snteita ).0%8( They found het ngiwlolfo NP e v e n t s tath osla derurcco with high frequency ni normal onatiulopp :slortnoc yetixna , mild s-reepd s i o n tath( sliaf ot meet eht airetirc rof “major d e p r e s s i v e -l i k e )s"deoisep , and dilm eivtinogc im 圃

pairment sticifed( ni fewer than eerth tfo eh tghie s p e c i f i e d veitnigoc .)sniamod Based on the stluser from siht study , they proposed defiidom airetirc rof NPSL .E I n a peivectpsor retnc, e-elgnis torcoh study up fo t o 7 years conducted by Hanly aFte 6 ) , 213 (63%) fo

209 stnetiap demonstrated ta tsael one NP event ( 2 9 9 svente atot )ldezieratcrahc by teh ACR asec d e f i n i t i o n s , but nlyo 13 % tfo he latot sevent were -ta t r i b u t e d SLot .E They used noisiced selur gndilucin t h e abovementioned iedodifm airetirc by Aaalini te aF 7 ) determine ot het noitubirtta NP efo s.tnev Fur -thermore , Hanly ate F 8 ) demonstrated ni an i-anretn t i o n a l niotpceni tohorc study taht 486 fo,1206 -ap t i e n t

s %).304( had ltatsae 1 NP event over a mean f o l l o w -u p fo .19土1. 2 y.srae The ntioorropp fo NP e v e n t s dteubritta ot SLE drieva from yonl 13.0% (most tngenrits model NPSLE) fo ot 23.6% ta( tsael s t r i n g e n

t model fo NPSLE) fo.stneitap The most f r e q u e n t snoitubirtta ot SLE fociratihcysp sevent ( t h e oitar fociratihcysp tsenev detbuirtta ot SLE over eht latot citraihcysp )stneve were seen ni -yps c

h o s i

s , from 571.% (eht most tnengitrs model fo NPSLE) ot 92.9% eht( tsael ntengitrs model fo T a b l e 1 Edetamist ecnelaverp pcfiortaihcys semordyns ni SLE nda ehtoitar tfoehnoitubirtta ot SLE E s t i m a t e d becnelaverp .oN pfoyramir NPSLE .oN/stneve tfolato NP estnev C)%( P s y c h i a t r i c semordnys a % I%C59 tsoM tnegnirts NPSLE ltAtsae tnegnirts NPSLE Mood redrosid 7.02 1.713-5 4. 931/81 )%9.21( 931/74 )%8.33( C o g n i t i v e noitcnufsyd 7.91 0.63-7.01 34/8)%6.81( 34/22 5(.1)%2 A n x i e t y redrosid 64. 6.31-0.3 24/0 ( 0)% 24/0 ( 0)% P s y c h o s i s 6.4 -24.8.8 41/8 75()%1. 41/31 )%9.29( A c u t e lanoisufnoc etats 34. 1.31.01- 22/11 ( 5)%0 22/71 )%3.77( a D e f i n e d tyb eh naciremA egelloC foygolotamuehR erutalcnemon dna esacsnoitinifed cirrotafihcysporuen supul s y n d r o m e s .)9991( b E s t i m a t e d sis myyblana-ate gnisu e-modnar 旺e'stc ledom Uybnamretn te a,l0102 4). C F r o m lano iintaanretn esaesid noitpecni trohoc SLE fo stneitap Hybylna tela, 0102 18 ). N P S L E : cirtaihcysporuen cimetsys supul susotamehtyre :, ICecnedifnoc avretni .l

(3)

-E3-NPSLE); nietuca lanoisufnoc setats , 50% ot;%3.77 and nievitingoc noitcnufsyd , %6.81 51ot . 2% , elihw t h e tsael tneuqerf snoitubirtta SLE ot were nees ni a n x i e t y sredrosid , 0% t 0%; o and mood ni sredrosid , 1 2 . 9 % to 8.33 %. (nI siht dyuts , eht srohtua did ton c h a r a c t e r i z e whether eht mood sredrosid dedulcni d e p r e s s i v e , manic , ro mixed .)edosipe ughAltho many cirtaihcysp stneve were detubirtta ot -non SLE sesuca , soncificep seusac gnidulcni -retsocitroc o i d

s were shown nisiht .yduts bleTa 1 shows eht e s t i m a t e d cenelvaerp focirtaihcysp syndromes d e m o n s t r a t e d ni eht denoitnem-evoba -tame a n a l y s i s foseiduts gnitagitsevni NPSLE gniylpap t h

e 9991 ACR esac snoitinifed 4) and the oitar tfo eh a t t r i b u t i o n ωot SLE shown tnisih ωs坑ydut Based on fsgnidni from evitcepsorp

coho0ぽ2tr)

91ω) and 則0 c a s e -c o n t r o l l 22υ)2山l却2幻)seiduts , eht European League A g a i n s t Rheumatism (EULAR) hcareser t-micom t e e)3d2eifitnedi major ksir srotcaf rofcirtaihcysp m a n i f e s t a t i o n s fo imarypr NPSLE sa:swollof )1( g e n e r a l esaesid ytivitca fo SLE yllaicepse( rof -es v e r e evitingoc )noitcnufsyd

)2( suoiverp stenve o r oreht tnerruncoc NPSLE snoitatsefinam 0 )2, and )3( p e r s i s t e n t l y evitisop dipilohpsohpitna seidobitna ( e s p e c i a l l y rofereves-ot-etaredom evitingoc -syd f u n c t i o n ) 2 )l122. C o r t i c o s t e r o i d -i n d u c e d cirtaihcysp rerdoisd ( C I P D ) An eylra egral sisylana-atem ssorca c92lacinil -fe f i c a c y seiduts fdiooretsocitroc ypareht rof lareves m e d i c a l snoitidnoc detarstnomed taht eerves -ysp c h i a t r i c syndromes edrurcoc ni 0%-52 , a wdightee a v e r a g e 5fo 7%. , and dlim ot atemoder syndromes i n 2%3-61 , a wdightee egareva 2fo.)42%8 dingccorA t o ansisylana fodehsilbup esac stroper fo CIPD syndromes , ereht was mania ni %; d53 noisserpe ni

2 8 %; mania and noisserped ni %; d21 muirile ni 13%; and sisohcysp ni 11 % お ) nteecR seiduts )72)62 h a v

e edstgeugs taht mania si eht most commonly o b s e r v e d ensopesr ot etuca ypareht hitw ylevitaler h i g h sesdo fsodioretsocitroc , elihw noisserped si l i k e l

y more common anth mania gnirud mert-gnlo t r e a t m e n t hitwsdioretsocitroc .7) Moreover sdioretso, citroc eraylgnisaercni -hgih l i g h t e d bsa gine detaicossa thiw evitingocoruen -mi p a i r m e n t .)6 )822 The most ylevisnetxe dertoper -ingoc t i v e seangch gnitluser omrf dioretsocitroc -taert ment evlovni evitaralced )labrev( memory , and co 剛

c u r r e d ngirdu thbo mret-trohs )esod-hgih( )62 and l o n g -t e r m ylevitaler( )esod-wol )03-)82 seipareht , -er f l e c t i n g a htnedepn-sdempucaopip ssecrop .)7 -ruF t h e r m o r e , even ereves evitingoc sredrosid hucs sa d e m e n t i a and muiriled have nbee edtroepr 1 ).3 A rtnece troper from eht UK ungis egral spleams o f erov 073 ,000 stneitap ni a pryimar erac gnittes showed taht eht rdzaah oitar rofladicius roivhaeb i nstneitap detaert thiw sdioretsocitroc was 9.6 ni c o m p a r i s o n potelpoe hitw eht same gniylrednu -sid e a s e s who were ton ;desopxe rof noisserped , .1;8rof mania ;3, .4 rof muiriled no, isufnoc , dnrooitatneirosi , 5.1 ; and rof cinap redrosid , .12 )53. erargL yliad sesod o f csdioretsocitro , a proir yrotsih nfo-taihcysporue r i

c sredrosid , and a psuoiver yrotsih CIPD fo were a s s o c i a t e d htiw a gretaer ksir CIPDfo 2 ).3 rheigH -roc t i c o s t e r o i d esgaosd yl, laicepse 三04 mg/ dya sa p r e d n i s o n e 3 )3, have been demrifnoc nilareves -duts i e s tsa eh most ntatorpim ksir rotcaf rof s.PDIC To desnogai stneitap hsa ngvia CIPD , eseht -duts i e s aveh been deilppa eht airetirc fo-ecnatsbus i n d u c e d cirtaihcysp sredrosid ni areneg .lFor exam -p l e , ni modern citsongaid smetssy ., g.e , eht -eriAm c a n cirtaihcysP s'noitaicossA citsongaiD and -sitatS t i c a l Manual Mfo talen sredrosiD , ht4 noitide (DSM-I V ) 3 4 l , eseht sredrosid were denifed fsa:wollo )1( eht p s y c h i a t r i c symptoms edplovede retfa gnriud , ro w i t h i n a month foecnastbus noitacixotni ro -htiw drawa ,l and )2( noitaicdem esu was yllacigoloite -er l a t e d tot eh.ecnabrutsid The citsongaid airetirc -pa p l i e

d ni ylrae seiduts fo CIPD were eht same ni p r i n c i p l e sa eseht modern .airetirc However , -epse c i a l l y eniylra seiduts , desnoagdisim sesac htmig be i n c l u d e d esucabe rehto seigoloite were .dekoolrevo Impact CIPD of on pstneita thwi SLE SLE ash been dertoper osa ne tfo eh ksir srotcaf f o r CIPD tnieh denoitne-mveoba sisylana-atem 4 ).2 nI t h e sisylana , eht ecnedicni pfocirtaihcys syndromes i nstneitap who deviecer dioretsocitroc yaprhet rof SLE was %2.93 dethgiew( .)egareva The ecnedicni r a t e was yltnacifingis rehgih anth eht %.75 -icni d e n c e nese when llasesaesid , hsuc sa lymphoma ,

(4)

m u l t i p l e sisorelcs evit, areclu sitiloc , ro idatoeumrh a r t h r i t i s , were deredisnoc .rehtegot R e c e n

t two trohoc seiduts by Chau and Mok お)

and aimurNish ate1 63 ) datestrmoned eht ecnedicni fo CIPD ni SLE stneitap detaert htwi sdioretsocitroc u s i n g ta scirt noitinifed and evnsiehemproc -songaid t i c euredocpr gnidrocca tot eh DSM-IV airetirc 43 ) . nI b o t h seiduts , eht common gniwollof tcirts noitinifed o f CIPD was ed:employ tesno-wen cirtaihcysp symptoms taht deopleved nihtiw 8 weeks if-oaitin t i o n aro ionattnemgu cdfiooretsocitro yaperht and t h a t devloser yletelpmoc hguorht a rnoitcude ni c o r t i c o s t e r o i d eagosd and touhitw lanoitidda -mi m u n o s u p p r e s s i v e .stnega

Chau and Mok 却dteroper taht CIPD edrurcoc ni

s i x stneitap (5%) fo a pevitcepsor trohoc 9fo p2 -a t i e n t s hitw SLE retfa ehtnoitaitini cdfiooretsocitro t h e r a p y . Of teh xis stneitap , eerht dpeoelevd -ysp c h o s i s and eht rehto eerht dpeloeevd mood -rosid d e r s htwi manic .serutaef arumihsiN te 1a63 ) -noc d u c t e d n oalanoitavresb yduts fo 161 evitucesnoc e p i s o d e s ni 515stneitap-ni htiw an SLE eralf who were detaert thiw.sdioretsocitroc retfA noisulcxe o f 2 e2 sedosip thiw nterruc trevo lartnec svouner s y s t e m snoitatsefinam SLE fo )ENS-SLC( , a d-ongai s i

s CIPD fo was made rof (41 01 1.%) 1fo 39 sedosipe i n 351 stneitap htiw a non-CNS-SLE eralf nihtiw 8 weeks cdifooretsocitro noitartsinimda by a p-aihcys t r i s .tcitohcysP sredrosid derrucco ni eon tenve (7%) , and mood sredrosid derrcuco ni 31 stnvee (93%) gn, idulcni evisserped serutaef ni two (14%) ,

manic serutaef nnieni 46(,)% and mixed serutaef ni two 41( .%) The ecnedicni CIPDs fo from eseht -duts i e s tmigh be udetmatieserdn esuaceb fo eht tcirts d e f i n i t i o n .desu nI eht rermof ytuds 却 ni which CIPDs were ton detualave by a ptsirtaihcys , a lrweo i n c i d e n c e CIPDs fo was edtropre nhat ni eht rettal s t u d y)638.4( % vs 101..)% dilM evitingoc noitcnufsyd may osla have been detaimsterednu ni thob seiduts , b e c a u s e ondeliated stnmessessa gnisu -syprouen c h o l o g i c a l stset were .demrorfep I n ea rvitcepsorte trohoc dytus fo 520 stneitap w i t h SLE , rleelzenppA te)7Padeifitnedi etuca -ysp c h o s i s ni (17%)98 , which fo eht lasuac breakdown was imarypr CNS tnemevolvni ni 95 , CIPD ni 82 , and unknown ni .owt sisochysP due ot aryprim NPSLE dtaesaesi tesno n(

=

)91 was detaicossa hitw d i s e a s e ytivitca , sisohcysp due ot yrimarp NPSLE d u r i n g pu-wollof SLE fo n(

=

)04 was detaicossa thiw p o s i t i v e dipilohpsohpitna seidobitna and ssel -erf q u e n t l y thwi laner and suoenatuc nemelvovni ,t and t e n 2fo p8stneita thwi CIPD had aoalbuminemihyp when sisohcysp .depoleved

Risk rsotcaf orf CIPD pnistneita thwi SLE Hypoalbuminemia sah enbe dettarnsomed bot e a r i s k rotcaf rof CIPDs ni SLE stneitap 53 ) 3 8 ) , utb eht p r o p o s e d mechanism sinmare .evitaluceps nI eht a b o v e -m e n t i o n e d evitcepsorp dytus by Chau and Mok 35 ), hguohlta ksir srotcaf rof CIPD dedulcni low

serum slevel fo nimubla , complemen ,t and -erc

a t i n i n e , a hyrotsi afoyteixn sredrosid , and a fylima h i s t o r y pfocirtaihcys sessenlli , ylno e-nimulbpoahy mia demainer tnacifingis retfa etairavitlum -tsujda men .t I n gaeren ,lniarb damage droesaesi any fo loite 剛 ogy may esopsiderp a pnsore otdecudni-ecnatsubs p s y c h i a t r i c sredrosid chus sa muiriled .)93 lareveS s u b c l i n i c a l CNS-SLE sgnidnif .g, .e , mlaoranb -ortcele e n c e p h a l o g r a m G)EE( , citengam encnaoesr ingimag ( M R I ) tfoeh niarb , crolanipsorbere diulf )FCS( dnif 田 i n g s , era deversbo ni SLE stneitap , sseldrager fo whether yeht tibihxe tnerruc trevo NP symptoms 9 ) . T h i s lacinilc srolacinilcbu CNS tneemlvovni due ot SLE tmigh esopsiderp a ptneita Cot PD.I -E5-I n teh evitcepsorp dyust 1fo 35 stneitap hitw -non CNS-SLE eralf by Nurashimi te la円evitisop -Q a l b u m i n (CSF /serum numilba ;oitar n iarotacidn fo b l o o d -b r a i n reirrab ]BB[B )egamad and e-mplocoyph mentemia were deifitnedi isa tenndpeden ksir -caf t o r s rof CIPDs gnisu a melpitlu citsigol noisserger a n a l y s i s . evitisoP minbula-Q was detceted niylraen h a l f eht CIPD sedosipe wro thi evitca CNS-SLE , -la t h o u g h compared hitw sedosipe which ni no p-ihcys a t r i c stneve depoleved s, level fo minbualQ- were h i g h e r tni eh CIPD sedosipe , and even rehigh ni-ca t i v e CNS-SLE .sedosipe The srohtua detaluceps t h a t BBB damage ightm aebdetaicoss thwi NPSLE and CIPD , hguothla no lasuac sknil have nbee p r o v e n .

(5)

T a b l e 2 elbissoP lamordnys sesongaid otpleh ni d i s t i n g u i s h i n g CIPD morf NPSLE

More common NPSLE ni

A c u t e lanoisufnoc /etatsmuiriled P s y c h o s i s C o g n i t i v e noitcnufsyd etar, edom otereves L e s s common NPSLE ni A n x i e t y redrosid M o o d redrosid evisser, ped edosipe d, lim

More common CIPD ni

M o o d redrosid dexim/c, inam edosipe a E s p e c i a l l y retfa etuca esod-h, gih dioretsocitroc .ypareht C I P D :i-dioretsocitroc n d u c e d cirtaihcysp redrosid , :ELSPN n e u r o p s y c h i a t r i c cimetsys supul.susotamehtyre NPSLE dregegrit by c?sdioretscoitro The noitautis siosla detcaiplmoc by teh -iripme c a l l y wnwell-kno tcaf taht tnesoe-wn NP symptoms i n SLE stneitap on csdioretsocitro dluco be due ot CNS. 圃SLE and tno a CIPDot

9 ) . A review 1fo 0 sesac o f etcua CNS snoitcailpmoc ni SLE stneitap retfa c o r t i c o s t e r o i d eslup yrapthe showed taht issochysp o c c u r r e d ni ruof stneitap , seruzies ni eerth , and h e m i p l e g i a ni ruof 40 ) . Although siht ecnreurcco fo n e u r o l o g i c syndromes edestggus sngis fo NPSLE , t h e r e was elttil lacigoloisyhpohtap noitarmofni ni t h i s .weiver Tabata ate1 4 1 )edrtoepr ca pirtaide SLE c a s e who showed CNS snoitatsefinam nihtwi 2 days a f t e r dioretsocitroc eslup .ypareht Both tfoeseh -er p o r t s , however , showed ylno a clacigolonorh -aler t i o n s h i p between dioretsocitroc noitartsinimda and p s y c h i a t r i c .snoitatsefinam I n teh lanoitavresbo ytuds by Nishimura te la叫, d u r i n g eht 8 weeks cfdoioretsocitro noitartsinimda , new cirtaihcysp sntvee rdecruco 2ni 0 (41 4.%) tfo eh 1 3 9 sdeosiep ni 531 stneitap ithw a non-CNS-SLE f l a r e . Of teh 0 p2stneita , two .1( 4 %) were dsenoiagd a

s CNS-SLE , and othb detneserp .muiriled Even

p r i o r ot eht cirtaihcysp snoitatsefinam , both -ap t i e n t

s had ydarela shown abnormal sgnidnif -gus g e s t i n g CNS involvemen ,t.g.e , EEG esitilamronba ( d i f f u s e .)gniwols llA tfo eseh sgnidnif improved ni p a r a l l e l thiw eht'stneitap seirveocer through -gua m e n t a t i o n fo immunosuppressive .ypareht sThi s t u d y tsesggus taht dioretsocitroc ypareht sreggirt CIPD and CNS-SLE nistneitap hitw SLE. muriliDe may be sevtiseggu CNS-SLEfo , leihw mood -rosid

d e r

s thiw manic/ mixed serutaef may be more -gus g e s t i v e CIPDfo 3制 2 ) D i a g n o s t i c and ctieuaprhet sonitaredsinoc forNPSLE Because tfo eh necesba a dfo citsongai dlog -nats d a r d rof NPSLE and seuaceb sforalimi irolacitned p s y c h o p a t h o l o g y thiw CIPD , eht sisongaid fo-irp mary NPSLE dulosh be adveeihc ylegral by a p-cor e s s efonoisulcx sfo yradnoce oro reht essauc NP fo m a n i f e s t a t i o n s and dlouhs be ddeivre from a clufera a n a l y s i s tfo eh acinilc ,lyrotraobal , and g-imaeuron i n g atad on a cesac-yb-esa sisab 凶)32 The citsongaid snoitagitsevni rof NPSLE tsisnoc o f teh:gniwollof )1( measurement afoseidobitnaotu ( e . .g, anoureintna ,llamosobiritna P, and -sohpitna p h o l i p i d ;)seidobitna )2(sisylana fo CSF ot deuclex i n f e c t i o n , ssessa eht BBB noitcnuf , and measure a u t o a n t i b o d i e s , yraotmmalfni soriatedm and -arged d a t i o n ;snietorp )3( EEG ;tnemsssesa )4( y-sopuren c h o l o g i c a l assessmen ;t)5( agnigimrouen eotetaulav b r a i

n erutcurts (computed tomography CT][ , MRI ,

m a g n e t i z a t i o n refsnart igngami [MTI] -no, isuffid w e i g h t e d image [DWI] rosnet-, noisuffid imaging [ D T I ] ) and niarb noitcnuf nortisop( onisisme -ot mography [PET] e, lgnis notohp niosisme computed tomography [SPECT] , ectingam ecansoner -ceps t r o s c o p y [MRS] , and lanoitcnuf MRI) .)41 citsonagiD v a l u e s rof NPSLE rof each tset and tenatmret fo NPSLE eraelbaliava onireht ewrevi selcitra 31 )1仰 R e c e n t seiduts tseggus taht eht ngitneesrp -inilc c a

l syndrome may pleh nignihsiugnitsid NPSLE from .IPDC muriileD etuca( lanoisufnoc )etats , psy 圃 c h o s i s , and eervse-o-teatredom evitingoc -cnufsyd t i o

n may be more evtisgegsu fo NPSLE 6 )11)8, -epse

c i a l l y ni sseac accompanied by ksir srotcaf rof NPSLE .g.e( , edsarecni lraeneg esaesid ytivitca , -erp v i o u s sntvee oro reht tnerurcnoc NPSLE -atsefinam t i o n s , proyltnetsisre evitisop dipilohpsohpitna -itna b o d i 託sザe

r

玖9

mixed serutaef may be more evistegugs ぱ0fCαIPD ,

e s p e c i a l l y retfa eutca se, od-high dioretsocitroc -reht apy elbaT( )27)2 仰 3却5)日附)制

Management of CIPD SLE ni stneitap Because fo eht ycneddepen-esod on c-retsocitro o

i d

s rof eht development CIPDfo 制, CIPD -iteroeht

(6)

c a l l y dulhos be tdetare ithw sedo onictudre dro-si c o n t i n u a t i o n tfo eh .gurd Lewis ate F 4l dteorepr taht c l i n i c a l ryecover from CIPD rdecruco ni 4 % o9 3f 6 c a s e s dteaert thwi lyimps gnirpeat eht-retsocitroc o i d .egasod tnI eh sesac thwi SLE l, la CIPDs 41 -co c u r r i n g ni a pevticespor trohoc 1fo 53 SLE stneitap r e s o l v e d lytelempoc retfa dioretsocitroc agedos -er d u c t i o n a mean ot 3fo5.2 mg/ day egnar( , 54-51 mg/ d a y ) a mean ro 0fo96. mg/kg/ day egnar( , 2.08幻.0-7 銘8 mgダ/kg ダ/d白ay刊7今)aおs penoloisnder ♂)ω3泌紛6

Psy 戸7氾cho 叩pha 訂rma 舵cC

igolo symptomatic entatmtre

may be redirque depending on teh ytireves 0ぱfCIPD

O ぽr the tnemtaert 0ぱf SLE flesti ylra, lucitrap fi sedo r e d u c t i o n dronoitaunitnocsi cfsodioretsocitro si-mi p o s s i b l e . However , encdeive rof eht psychopharma-c o t h e r a p

y CIPD fo sha been very detimil with seac r e p o r t

s , a few llams easc seires , and a few llams

c l i n i c a l .l34l8slairt

For both ciothcsyp and manic/ mixed sedsoipe fo CIPD , lareves scitohcyspitna odirepolah( ,l-irepsir done , enipazanlo , ro)enipaiteuq and mood -zilibats e r s muihtil( , etaorplav , zeniperamabac , lro-girtoma i n e

) have been ylevitceffe used nilareves seac -er p o r t s l8制 . a cnI seires-esa dertpoer by Dsavi te 1 4a

t r e a t m e n t lfoesod-wo scitohcyspitna devloser -ysp c h o t i c symptoms 8ni % o3 pfstneita 42( tuo 2fo 9 p-a t i e n t s

) and edvolser symptoms nihitw 2 weeks ni 80% pfo.stneita a 5-week nI lebal-nepo lairt ofo-nal z a p i n e 02-5.2 mg/ day (mean 5.8 mg/ d)ya , 11 tfo eh 1 2 tsneitaptuo thiw manic ro mixed esdoispe fo CIPD showed marked improvement ithw no change eniladaimrypartx edis モ旺tce selacs , weight , o r gesoucl measurements 5 ).4 a cnI seires-esa tudys fo r i s p e r i d o n e tni eh mtnetaert CIPD fo ithw manic ro mixed serutaef snixi lemaef stneitap-ni with SLE 6 )4, marked ssenevitceffe rfoenodirepsi pu( ot a mean o f 30. mg/ d;ya geran , 9-1 mg/ d)ya was rdevbeso ni a l l stneitap ylralucitrap ni eht tsrif 2 w.eeks Except f o r noiatdes one ni tneitap and dilm msinonsikraP ni one neitap ,tllarevo eshet xis stneitap detarelot r i s p e r i d o n e llew thouwit ciolbatem edis e旺stce 6 )4,-la though combining noitarnee-gndoces scitohcyspitna such rsaenodirepsi , eniapznalo , qroeniapiteu ithw c o r t i c o s t e r o i d s dlouc show an evitidda tceffe ni terms mfocliobate syndrome. -E7-Use focilcycirt stnasserepditna (TCAs) rof c o r t i c o s t e r o i d 園ducedin noisserped sha been -ruocsid

aged auseecb TCAs netfo etaerbacxe rieht symp-t o m s 8 ) )34. Meanwhile luf, sseccus esu sfoevitcele -ores t o n i n keuptaer srotibihni enitexoulf( ro)enilartres and nniotores enriphnepieron ekatpuer srotibihni , such saenixaflanev , have been estedsugg ni esac r e p o r t s , but no clacinil slairt have been .edtucdonc L i t h i u m sah been dsteeggus saevitceffe rof thbo manic and veissepred sedosipe fo CIPD snilareve c a s e stroper .)348) C o n c l u s i o n s and eurfut snoitecrid

The laitnereffid sisongaid NPSLE fo and CIPD er 町

mains gnginellahc ni.ecitcarp Recent seiduts -gus g e s t muiriled etuca( lanoisufnoc )etats , ssiochyps , and ereveso-t-etraedom evitingoc noticunfsdy may be more evtiseggsu NPSLEfo 山)0山-)6 山)2ylla,icepse i n sesac accompanied by ideasercn lareneg esaesid a c t i v i t y , suioevrp tsenev , rehot trencurcon NPSLE m a n i f e s t a t i o n s , royltnetsisrep evitisop -sohpitna p h o l i p i d seidobitna

~

yleservnoC ,mood sredorsid w i t

h manic/ mixed serutaef may be more -esgugs t i v e CIPDfo ylla, icepse retfa etuac , esdo-hgih -itroc c o s t e r o i

d rapyhet ))6224))763)5幻3) However , NPSLE and

CIPD anc hbot tneesrp ssorac a spectrum pfo-ihcys a t r i c s.ndromesy yllaicepsE ni sesac gnitibihxe -ed l i r i u m mroereveso-t-etardeo evitingoc noitcnufysd , o t h e r sseauc ., g.e noit, cefni mro ciolbate -ilmarnoba t i e s , ldoush be e.dedulcx Thus l, uferac citsongaid -ni v e s t i g a t i o n s gnidulcni acinilc ,lyroatrobla , and niarb i m a g i n g sgnidnif dulhos be ctdeocudn on a cyb-sea 圃 c a s e sisab ot enmierted eht tseb lasuac noitubirtta f o

r cirtaihcysp syndromes ni SLE .stneitap Addi 回

t i o n a l and regral dellortnoc seiduts era needed ot c l a r i f y het ssieneogthap focirtaihcysp syndromes due bot oth NPSLE and CIPD ottucrtnsoc an a-ed q u a t e idla旺itnere management ygetatrs rof eseht c o m p l i c a t e d .snoitidnoc The srohtua troper o fnlaicnani ororeht pihsnoitaler r e l e v a n t toteh stcejbus tfosih.elcitra R e f e r e n c e s 1 ) alainiA H, lakoukoL Jalo, tleP J e at:l The -averp l e n c e cirtfaihocysporuen seomrdnsy nicimetsys l u p u s .susotamehtyre ygolorueN :75 005-694 , 1002

(7)

2 ) Brey RL , yidallHo SL , Saklad AR e at:l Neu -r o p s y c h i a t r i c syndromes lni:supu encealverp ngisu s t a n d a r d i z e d .snoitinifed ygoloreNu :85 0212-2411 , 2 0 0 2 3

) Hanly JG , McCurdy G , Fougere L e at:l -opsyeurN c h i a t r i c stnvee niicmestys uspul :usosatmheyter a t t r i b u t i o n and lacinilc .ecnacifingis J Rheumatol :13 2 1 5 6 -2 1 6 2 ,0420 4 ) Unterman A, eltNo JE , Boaz M e alt : sy-ropNeu c h i a t r i c syndromes niicmtessy supul o-tmaheyter s u s : .sisya mlana-ate Semin sitirhtrA Rheum :14 -1 1 1 . 2 0 1 1 5 ) ltaosP Mt, allatsoC LT , reellzpnepA :S-psyuroNe c h i a t r i c snoitatsefinam sniciemtsy spuul ma-therye t o s u s : ygloiomdepie ygo, lioshyphoatp and manage-men .tCNS Drugs :52 6731-27 , 1102 6

) Wolkowitz OM , Reus VI , Canick J e at:l -rococulG t i c o i d noiatcdiem , memory and diorets sishocysp ni m e d i c a l .ssenlli Ann NY Acad icS :328 961-8 ,9791 7 ) Brown ES: stceffE fosdiocitrococulg on mood , memory , and eht aspmucoppih tnemtaert and -erp v e n t i v e .ypareht Ann NY Acad icS :9711 41-55 , 2 0 0 9 8

) Dubovsky AN , Arvikar S, rnteS TA e at:l The n e u r o p s y c h i a t r i c snoitacilpmoc fodiocitrococulg u s e : diorets sisohcysp .detisiver scitamsoohcysP :35 1 0 3 -1 1 5 ,2012 9 ) West G:SlacinilC tspcseA tfo eh N esuorv m.teysS I n'siobuD Lupus suasotmhteyrE and deatleR -nSy dromes eacllaW( D,J Hahn BH e)sd , pp368-381 , E l s e v i e r ersnduaS aihple, dalihP 02( )3l 1 0

) Bhangle SD , Kramer N , nisetnesoR ED: -itroC c o s t e r o i d dceduin cirtaihcysporuen :sredrosid -er view and tsartnoc htwi cirtahicysporuen .supul Rheumatol tnI :33 23193-291 ,1320 1 1

) Kohen M, Asherson RA , Gharavi AE e at:l Lupus p s y c h o s i s : noitaitnereffid from ehtdecudni-diorets s t a t e . nilC Exp :11atolmuehR 6233-23 ,9391 1 2

) Denburg SD , eottarbC RM , Denburg JA: -itroC c o s t e r o i d s and lacigoolhcypsorune gninoitcnuf ni p a t i e n t s thwi ciemtyss supul .susotamehtyre -rA t h r i t i s Rheum :73 0231-1131 , 4919 1 3 ) siasrtBe GK , Boumpas DT: siseneoghtaP , -ongaid s i

s and management nfocirtaihcysporue SLE i-nma f e s t a t i o n s . Nat Rev t61o:amuehR 763-853 , 0012 1 4

) Hanly :GJ siosngaiD and management nfoy-psoure c h i a t r i c SL.E Nat Rev t:0lolamuehR 743-833 , 4012 1 5

) ACR Ad Hoc Committee on Nctriiacyhpsuroe

Lupus :emenclaturNo The American egelloC fo Rheumatology uremenclatoN and eCsa snoitinifeD f o r ciratichysporueN Lupus o.semSrdny sitirhtrA Rheum :24 08-6995 , 9991 1 6 ) Hanly JG , Su L, arewellF V e at:l evitecpsorP s t u d y nfocirtaihcysporue stneve nicmiestys uspul e r y t h e m a t o s u s . p u slanoitanretnI gnitaroballoC scinilC CC):(SLI P r o s p e c t i v e sisylana nfocirtaihcysporue tsnvee ni a n ianoitanretn l esaesid noitpecni trohoc pfostneita w i t h icmestys supul s.uostaemhytre Ann Rheum D i s :96 553-295 , 102 0 1 9 ) Mikdashi J, Handwerger B:srotciderP fo -uen r o p s y c h i a t r i c damage niciemtssy supul -emathrye t o s u s : atad from eht Maryland supul rhooc .t-heuR m a t o l o g y )drofxO( :34 06515-551 , 0420 2 0 ) Bujan S, si-RoOrd J, dseeraP J e at:lnoitubirtnoC o f tehlaitini serutaef sfoicmtesy supul aotthemyre 司 s u s totehlacinilc noitulove and lavivrus a cfo rtoho o f Mnaenraretied .stneitap Ann Rheum siD :26 -859 8 6 5 ,3020 21) Tomietto P, Annese V, intiosgA'D S e at:l larneeG and cificeps srotcaf detaicossa thwi ytireves cfo og 幽 n i t i v e entairmimp ni cimtesys supul oathemryte ・ s u s . sitirhtrA Rheum :75 247-11461 , 7002 2 2 ) Sanna G, iniccalotreB ML , Cuadrado MJ e at:l N e u r o p s y c h i a t r i c snoitatsefinam niicmtessy supul e r y t h e m a t o s u s : ecenlvaerp and noitaicossa thwi -na t i p h o s p h o l i p i d .seidobitna J Rlotmaueh :03 92-9859 , 2 0 0 3 2 3 ) siasrteB G, sidninaoI JP , siteloB J e at:l Task F o r c e fo eht EULAR gnidnatS Committee rof -nI t e r n a t i o n a l lacinilC seidutS gnidulcnI :sictueparheT EULAR dsnotainmmeroce rof eht management fo s y s t e m i c supul .susotamehtyre teporR fo a Task F o r c e fo eht EULAR gnidnatS Committee rof -nI t e r n a t i o n a l lacinilC seidutS gnidulcnI .scitueparehT Ann Rheum siD :76 520-591 ,0820 2 4

) Lewis DA , Smith RE: decudin-dioretS cirtaihcysp s y n d r o m e s . A rtrope fo 41 sesac and a rwieev fo t h e.erutaretil J A旺e't Dcrdois :52339-13 ,3891 2 5 ) sioriS :FdioretS :sisohcysp a r.weive Gen Hosp P s y c h i a t r y :52 3-327 , 3002 2 6

) Naber D, Sand P, leigH P:Blaicgolohatpohcys and n e u r o p s y c h o l o g i c a l stceffe 8fo'syad- dioretsocitroc t r e a t m e n .tA pevictepsor .yduts od-eoneuronchysP c r i n o l o g y :12 1-352 , 6991 2 7

) Brown ES , pespuS T, Khan DA e at:l Mood c h a n g e s ginurd enosinderp stsrub nistneitaptuo w i t h a.mhsta J Cnil locaamrhhpocysP :22 55-6 ,1 2 0 0 2 2 8 ) Keenan PA , Jacobson M W , minaeyloS RM e alt : The tceffe on memory cfocinorh enosniderp taert 四 ment nistneitap hitw ciemtsys .esaesid yologeurN 4 7 : 1 3 9 6 -1 4 0 2 ,6991 2 9 ) Brown ES , Vera E, Frol AB e at:l stceffE fo c h r o n i

c ensoidnerp ypaerth on mood and memory. J Atceff dorsDi :99 3289-27 , 0702 3 0 ) iaccluCo D, Wolf OT , sailloK S e at:l-itrococulG c o i d decudin-ypaerht memory :sticifed etuca -rev s u s cinorhc e.旺stce J Nicsorue :82 84734-473 ,

(8)

3 3

) The Boston evitaorblaloC Drug ecnalleivruS Program: Acute eserdva noitcaer otenoloisnderp i n rnoitale ot.egasod nilC loarmachP Ther :31 -694 6 9 8 , 7291 3 4 ) American citrahicysP :noitaicossA citsongaiD and lacitsitatS Manual Mfolatne sredrsoiD , ht4( )de . American cirtaihcysP noitaicossA , gnotsnihaW , DC ( 1 9 9 4 ) 3 5 ) Chau SY , Mok CC: srotcaF evitciderp fo-itroc c o s t e r o i d sisohycsp nistneitap thwi cimetyss supul e r y t h e m a t o s u s . gyuroloNe :16 07-1410 ,0302 3 6 ) Nishimura K, gaiHari M , Omori M e at:l lB-doo b r a i n reirrab damage sa a rksi rotcaf rof c o r t i c o s t e r o i d -i n d u c e d cirtaihcysp sredrosid ni-sys t e m i c supul .ussoatmhetyre i-crondoeureonchsyP n o l o g y :33 03-4953 , 8002 3 7 ) lernzelppeA S, Cendes F, tallatsoC LT: Acute p s y c h o s i s niicmtessy supul .suosatmhetrye -Rheu m a t o l l n t 2 8 : 2 3 7 -2 4 3 ,8002 3 8 ) Lo r pez-Medrano F , Cervera R , ojerT 0 ate:l S t e r o i d dceduni issohcysp ni cimetsys supul e r y t h e m a t o s u s : a pelbisso elor fo serum minlbua l e v e .lAnn Rheum sDi 61: 3652-65 , 0220 3 9 ) i powski L :JZ :muirileD Acute lanoisufnoC etatS , O x f o r d ytiservinU sserP , New York )0991( 4 0

) Wysenbeek AJ , iciovbieL L, Zoldan :J Acute -nec

t r a l svouern emytss snoitacilpmoc retfa eslup -rets o i d yaphert pnistneita hiwt cmietyss supul -ehtyre m a t o s u s . J :t7lolamuehR 96165-916 , 9091 41) Tabata Y, roihcI K, Kawamura N e at:l lartneC n e r v o u s system snoitatsefinam retfa diorets eslup t h e r a p y sniciemtys supul .ssuoatmethyre Eur J -eP d i a t r 6 11:.405-305 0220 4 2 ) Nishimura K, Omori M, Sato E e at:l -onsetNew p s y c h i a t r i c sredrosid retfa dioretsocitroc yaperth i n icmtessy supul :susoatmehtyre laa onoitavresb c a s e -s e r i e s .yduts J :126o1ureN 85210-512 , 4012 4 3 ) Kenna HA , Poon A W , lde so lseAegn CP e at:l P s y c h i a t r i c snoitacilpmoc fontetmeart ithw itroc 同 c o s t e r o i d s : iewrev hitw esac roper .tyrtaihcysP nilC N e u r o s c i :56 0569-54 , 1012 4 4

) Davis JM , Leach A , Merk BS e at:l Treatment fo s t e r o i d .sesohcysp ratihcysP Ann :22 497-84 ,12919 4 5

) Brown ES , Chamberlain W , Dhanani N e alt : An o p e n lebal lairt foenipaznalo rof-dioretsocitroc i n d u c e d mood symptoms. J tceffA drsoiD :38 7-27 2 8 1 ,0420 4 6 ) Nishimura K, Omori M , toSa E e at:l eondierpsRi i n eht tentmeatr decfudnio-dioretsocitroc mood d i s o r d e r s , manic/mixed sedosipe niicmtessy suplu e r y t h e m a t o s u s : a cesa seires .yduts Psychosomat 開 i c s :35 93-2928 , 2012 神経精神ループスとステロイド誘発性精神障害ー精神医学の観点から 東京女子医科大学医学部精神医学講座 西 村 勝 治 ・ 石 郷 岡 純 全 身 性 エ リ テ マ ト ー デ ス cemitsy(s slupu erythematosus : SLE) は 頻 繁 に 神 経 精 神 病 変cirtaihcysporuen(

SLE: NPSLE) を合併する.しかしそれらが活動性の SLE に直接由来するものなのか, SLE やその治療に間接的

に関連するものなのか,あるいはSLE とは無関係の作用によるものなのか十分知られていない.特にステロイ ド誘発性精神障害decudnid-ioertoscirto(c critiahcsyp errdsodi : CIPD) との鑑別はしばしば困難であり,治療に 難渋することも稀ではない.本稿では NPSLE とCIPD の臨床的側面に関する文献のレビューを行った.エビデン スは限られているが,せん妄,精神病性障害,中等度から重度の認知機能障害の場合,特にNPSLE の危険因子 (全般性の疾患活動性の充進, NPSLE の既往歴,他のNPSLE 症状の併発,抗リン脂質抗体の持続陽性)を有して いれば, NPSLE であることがより示唆される.一方,操病あるいは混合性の特徴を伴う気分障害の場合,特に急 性,高用量のステロイド治療後に生じたときにはCIPD であることがより示唆される. しかしながら, NPSLE とCIPD とはいずれも同じスペクトラムの精神症候群を呈しうる.このため基本的にはケース・バイ・ケースに ラボデータ(血清および髄液)や脳画像を含む慎重な鑑別診断を行うべきである.

参照

関連したドキュメント

これらの定義でも分かるように, Impairment に関しては解剖学的または生理学的な異常 としてほぼ続一されているが, disability と

相談件数約 1,300 件のうち、6 割超が東京都、大阪府、神奈川県をはじめとした 10 都

このような情念の側面を取り扱わないことには それなりの理由がある。しかし、リードもまた

( 同様に、行為者には、一つの生命侵害の認識しか認められないため、一つの故意犯しか認められないことになると思われる。

子どもたちは、全5回のプログラムで学習したこと を思い出しながら、 「昔の人は霧ヶ峰に何をしにきてい

個別の事情等もあり提出を断念したケースがある。また、提案書を提出はしたものの、ニ

基準の電力は,原則として次のいずれかを基準として決定するも

人間は科学技術を発達させ、より大きな力を獲得してきました。しかし、現代の科学技術によっても、自然の世界は人間にとって未知なことが